News: Variantyx Surpasses 2,500 Genomes Analyzed, Highlights the Value of Its WGS-Based Testing Methodology

Clinicians at Variantyx, a leader in high complexity hereditary disease testing, recently completed analysis of their 2,500th patient genome. The milestone highlights the growing need for whole genome sequencing (WGS)-based tests in patient genetic diagnostics …

Read More

Article: Helping Clinicians Solve Genetic Puzzles

In 2003, an international consortium of health institutes and government agencies completed “The Human Genome Project.” The scientific world considered the effort to sequence the three billion DNA letters in the human genome as one of the most ambitious of all time …

Read More

News: Variantyx Licenses IBM Technologies That Leverage AI for Somatic Analysis

Variantyx today announced that it has entered into a licensing agreement with IBM for technologies that leverage artificial intelligence for somatic analysis …

Read More

Variantyx Inc.

1671 Worcester Road, Suite 300
Framingham MA 01701 USA

Phone: +1 617-209-2090

  • This site is protected by reCAPTCHA and the Google Privacy and Terms of Service apply

Please do not submit Protected Health Information (PHI) through this email address.

If you need to submit Protected Health Information (PHI), please call us at 617-209-2090 and we will work with you to submit the information through an alternate mechanism.

Otherwise, please continue: